Cefazolin – Injection products
FDA Identified Breakpoints
Minimum Inhibitory |
Disk Diffusion |
|||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacterales |
M-100 standard is recognized |
S = Susceptible; I = Intermediate; R = Resistant
Interpretive criteria are based on a dose of 2 g every 8 hr.
Separate susceptibility test interpretive criteria for Enterobacterales for therapy of uncomplicated urinary tract infections are not recognized at this time.